抗艾滋病毒药物阿巴卡韦刺激成骨细胞系细胞中β-catenin的活性

IF 3.4 Q2 ENDOCRINOLOGY & METABOLISM
JBMR Plus Pub Date : 2024-03-19 DOI:10.1093/jbmrpl/ziae037
Arnold Z. Olali, Jennillee Wallace, Hemil Gonzalez, K. A. Carpenter, Niyati Patel, Lee C Winchester, A. Podany, Ishwarya Venkatesh, S. Narasipura, Lena Al-Harthi, Ryan D Ross
{"title":"抗艾滋病毒药物阿巴卡韦刺激成骨细胞系细胞中β-catenin的活性","authors":"Arnold Z. Olali, Jennillee Wallace, Hemil Gonzalez, K. A. Carpenter, Niyati Patel, Lee C Winchester, A. Podany, Ishwarya Venkatesh, S. Narasipura, Lena Al-Harthi, Ryan D Ross","doi":"10.1093/jbmrpl/ziae037","DOIUrl":null,"url":null,"abstract":"\n Bone mineral density (BMD) loss in people living with HIV (PLWH) occurs with the initiation of combined antiretroviral therapy (cART), particularly with tenofovir disoproxil fumarate (TDF) containing cART. Switching from TDF to abacavir (ABC) or dolutegravir (DTG) leads to increased BMD. Whether BMD gains are due to cessation of TDF or anabolic effects of ABC or DTG is unclear. We investigated the effects of ABC and DTG on osteoblast lineage cells in vitro and in vivo. Primary human osteoblasts and male C57BL/6 mice were treated with individual antiretrovirals (ARVs) or a combination of ABC/DTG/lamivudine (3TC). Nearly all ARVs and cART inhibited osteogenic activity in vitro. Due to the importance of Wnt/β-catenin in bone formation, we further investigated ARV effects on the Wnt/β-catenin pathway. ABC, alone and as part of ABC/DTG/3TC, increased osteoblastic β-catenin activity as indicated by increased TOPFlash activity, hypo-phosphorylated (active) β-catenin staining, and β-catenin targeted gene expression. Mice treated with TDF had decreased lumbar spine BMD and trabecular connectivity density in the vertebrae, while those treated with ABC/DTG/3TC reduced cortical area and thickness in the femur. Mice treated with ABC alone had no bone structural changes, increased circulating levels of the bone formation marker, P1NP, and elevated expression of the Wnt/β-catenin target gene, Lef1, in osteocyte enriched samples. Further, bones from ARV-treated mice were isolated to evaluate ARV distribution. All ARVs were detected in the bone tissue, which was inclusive of bone marrow, but when bone marrow was removed, only TDF, ABC, and DTG were detected at ~0.1% of the circulating levels. Overall, our findings demonstrate that ABC activates Wnt/β-catenin signaling, but whether this leads to increased bone formation requires further study. Assessing the impact of ARVs on bone is critical to informing ARV selection and/or discovery of regimens that do not negatively impact the skeleton.","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Anti-HIV Drug Abacavir stimulates β-catenin activity in osteoblast lineage cells\",\"authors\":\"Arnold Z. Olali, Jennillee Wallace, Hemil Gonzalez, K. A. Carpenter, Niyati Patel, Lee C Winchester, A. Podany, Ishwarya Venkatesh, S. Narasipura, Lena Al-Harthi, Ryan D Ross\",\"doi\":\"10.1093/jbmrpl/ziae037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Bone mineral density (BMD) loss in people living with HIV (PLWH) occurs with the initiation of combined antiretroviral therapy (cART), particularly with tenofovir disoproxil fumarate (TDF) containing cART. Switching from TDF to abacavir (ABC) or dolutegravir (DTG) leads to increased BMD. Whether BMD gains are due to cessation of TDF or anabolic effects of ABC or DTG is unclear. We investigated the effects of ABC and DTG on osteoblast lineage cells in vitro and in vivo. Primary human osteoblasts and male C57BL/6 mice were treated with individual antiretrovirals (ARVs) or a combination of ABC/DTG/lamivudine (3TC). Nearly all ARVs and cART inhibited osteogenic activity in vitro. Due to the importance of Wnt/β-catenin in bone formation, we further investigated ARV effects on the Wnt/β-catenin pathway. ABC, alone and as part of ABC/DTG/3TC, increased osteoblastic β-catenin activity as indicated by increased TOPFlash activity, hypo-phosphorylated (active) β-catenin staining, and β-catenin targeted gene expression. Mice treated with TDF had decreased lumbar spine BMD and trabecular connectivity density in the vertebrae, while those treated with ABC/DTG/3TC reduced cortical area and thickness in the femur. Mice treated with ABC alone had no bone structural changes, increased circulating levels of the bone formation marker, P1NP, and elevated expression of the Wnt/β-catenin target gene, Lef1, in osteocyte enriched samples. Further, bones from ARV-treated mice were isolated to evaluate ARV distribution. All ARVs were detected in the bone tissue, which was inclusive of bone marrow, but when bone marrow was removed, only TDF, ABC, and DTG were detected at ~0.1% of the circulating levels. Overall, our findings demonstrate that ABC activates Wnt/β-catenin signaling, but whether this leads to increased bone formation requires further study. Assessing the impact of ARVs on bone is critical to informing ARV selection and/or discovery of regimens that do not negatively impact the skeleton.\",\"PeriodicalId\":14611,\"journal\":{\"name\":\"JBMR Plus\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-03-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JBMR Plus\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/jbmrpl/ziae037\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JBMR Plus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jbmrpl/ziae037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

艾滋病病毒感染者(PLWH)在开始接受联合抗逆转录病毒疗法(cART),尤其是含有富马酸替诺福韦二吡呋酯(TDF)的 cART 治疗时,会出现骨密度(BMD)降低的情况。从 TDF 改用阿巴卡韦 (ABC) 或多罗替拉韦 (DTG) 会导致 BMD 增加。BMD增加是由于停用TDF,还是由于ABC或DTG的合成代谢作用,目前尚不清楚。我们在体外和体内研究了 ABC 和 DTG 对成骨细胞系细胞的影响。原代人类成骨细胞和雄性 C57BL/6 小鼠接受了单个抗逆转录病毒药物(ARV)或 ABC/DTG/lamivudine (3TC) 组合的治疗。几乎所有抗逆转录病毒药物和 cART 都抑制体外成骨活性。由于 Wnt/β-catenin 在骨形成中的重要性,我们进一步研究了 ARV 对 Wnt/β-catenin 通路的影响。ABC(单独或作为ABC/DTG/3TC的一部分)增加了成骨细胞β-catenin的活性,表现为TOPFlash活性增加、低磷酸化(活性)β-catenin染色和β-catenin靶基因表达。接受TDF治疗的小鼠腰椎BMD和椎骨小梁连接密度降低,而接受ABC/DTG/3TC治疗的小鼠股骨皮质面积和厚度减少。单用 ABC 治疗的小鼠没有骨结构变化,骨形成标志物 P1NP 的循环水平升高,Wnt/β-catenin 靶基因 Lef1 在骨细胞富集样本中的表达升高。此外,还分离了接受过 ARV 治疗的小鼠骨骼,以评估 ARV 的分布情况。在包括骨髓在内的骨组织中检测到了所有抗逆转录病毒药物,但当骨髓被移除时,只检测到了TDF、ABC和DTG,其含量约为循环水平的0.1%。总之,我们的研究结果表明,ABC能激活Wnt/β-catenin信号,但这是否会导致骨形成增加还需要进一步研究。评估抗逆转录病毒药物对骨骼的影响对于选择抗逆转录病毒药物和/或发现不会对骨骼产生负面影响的治疗方案至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Anti-HIV Drug Abacavir stimulates β-catenin activity in osteoblast lineage cells
Bone mineral density (BMD) loss in people living with HIV (PLWH) occurs with the initiation of combined antiretroviral therapy (cART), particularly with tenofovir disoproxil fumarate (TDF) containing cART. Switching from TDF to abacavir (ABC) or dolutegravir (DTG) leads to increased BMD. Whether BMD gains are due to cessation of TDF or anabolic effects of ABC or DTG is unclear. We investigated the effects of ABC and DTG on osteoblast lineage cells in vitro and in vivo. Primary human osteoblasts and male C57BL/6 mice were treated with individual antiretrovirals (ARVs) or a combination of ABC/DTG/lamivudine (3TC). Nearly all ARVs and cART inhibited osteogenic activity in vitro. Due to the importance of Wnt/β-catenin in bone formation, we further investigated ARV effects on the Wnt/β-catenin pathway. ABC, alone and as part of ABC/DTG/3TC, increased osteoblastic β-catenin activity as indicated by increased TOPFlash activity, hypo-phosphorylated (active) β-catenin staining, and β-catenin targeted gene expression. Mice treated with TDF had decreased lumbar spine BMD and trabecular connectivity density in the vertebrae, while those treated with ABC/DTG/3TC reduced cortical area and thickness in the femur. Mice treated with ABC alone had no bone structural changes, increased circulating levels of the bone formation marker, P1NP, and elevated expression of the Wnt/β-catenin target gene, Lef1, in osteocyte enriched samples. Further, bones from ARV-treated mice were isolated to evaluate ARV distribution. All ARVs were detected in the bone tissue, which was inclusive of bone marrow, but when bone marrow was removed, only TDF, ABC, and DTG were detected at ~0.1% of the circulating levels. Overall, our findings demonstrate that ABC activates Wnt/β-catenin signaling, but whether this leads to increased bone formation requires further study. Assessing the impact of ARVs on bone is critical to informing ARV selection and/or discovery of regimens that do not negatively impact the skeleton.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JBMR Plus
JBMR Plus Medicine-Orthopedics and Sports Medicine
CiteScore
5.80
自引率
2.60%
发文量
103
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信